Stockreport

ImmuCell signals operational excellence and targets $30M annual production capacity amid management transition [Seeking Alpha]

ImmuCell Corporation  (ICCC) 
US:NASDAQ Investor Relations: immucell.com/investors
PDF Michael Brigham, Special Advisor to the CEO, described 2025 as an “exciting time at ImmuCell,” highlighting improved financial performance over the first nine months, a [Read more]